Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population
暂无分享,去创建一个
Michael D. Kappelman | Kristen R. Moore | Jeffery K. Allen | S. Cook | M. Kappelman | Suzanne F. Cook
[1] J. Lewis,et al. Incidence and Prevalence of Inflammatory Bowel Disease in a Northern California Managed Care Organization, 1996–2002 , 2008, The American Journal of Gastroenterology.
[2] C. Porter,et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. , 2008, Gastroenterology.
[3] D. Ollendorf,et al. Infliximab Drug and Infusion Costs Among Patients With Crohn's Disease in a Commercially-Insured Setting , 2006, American journal of therapeutics.
[4] Mieke Koehoorn,et al. The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study , 2006, The American Journal of Gastroenterology.
[5] R. Platt,et al. Estimation of the Period Prevalence of Inflammatory Bowel Disease Among Nine Health Plans Using Computerized Diagnoses and Outpatient Pharmacy Dispensings , 2007, Inflammatory bowel diseases.
[6] R. Cohen,et al. Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment , 2008, Inflammatory bowel diseases.
[7] William J. Tremaine,et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.
[8] W. Mow,et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. , 2010, The Journal of pediatrics.
[9] R. Hoffmann,et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. , 2003, The Journal of pediatrics.
[10] C. Porter,et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease , 2011, Inflammatory bowel diseases.
[11] Ken Kleinman,et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[12] J. Mauskopf,et al. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. , 2001, Respiratory medicine.
[13] A Wajda,et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.